Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE) - Concepedia

Concepedia

Publication | Open Access

Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE)

DOI Full Paper Access

49

Citations

24

References

2020

Year

P J George, Nathaniel Dasyam, Giulia Giunti, Brigitta Mester, Evelyn Bauer, Bethany Andrews, Travis Perera, Tess Ostapowicz, Chris Frampton, Peng Li,

Abstract

NCT04049513.

References

	Year	Citations

Page 1